DexCom, Inc. DexCom, Inc.

DexCom, Inc.

DXCM

Kedudukan dalam Saham #760
DexCom, Inc. is a medical technology company primarily focused on innovating,... DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.
Harga Saham
$85.59
Modal Pasaran
$32.30B
Perubahan (1 hari)
-0.45%
Perubahan (1 tahun)
25.08%
Negara
US
Perdagangan DexCom, Inc. (DXCM)

Kategori

Healthcare
Sejarah pecahan saham untuk DexCom, Inc. (DXCM)
Saham DexCom, Inc. (simbol: DXCM) telah mengalami sejumlah 1 pecahan saham.
Pecahan saham terkini berlaku pada Jun 13, 2022.
Satu saham DXCM yang dibeli sebelum Jun 13, 2022 kini bersamaan dengan 4 saham DXCM.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
2022-06-13 4:1 x4 x4
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
9 x285
US
7 x127
IE
9 x162
US
2 x4
US
0 -
DE